{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:48:55Z","timestamp":1763225335960,"version":"3.45.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,15]]},"DOI":"10.7759\/cureus.96915","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:43:21Z","timestamp":1763225001000},"source":"Crossref","is-referenced-by-count":0,"title":["Renal Medullary Carcinoma: A Call for Screening and Early Diagnosis"],"prefix":"10.7759","author":[{"given":"Harikrishna Choudary","family":"Ponnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Shirsat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saketh","family":"Parsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Sonavane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Ravakhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20764","article-title":"Cytologic features of renal medullary carcinoma","volume":"105","author":"Assad L","year":"2005","unstructured":"Assad L, Resetkova E, Oliveira VL, Sun W, Stewart JM, Katz RL, Caraway NP. Cytologic features of renal medullary carcinoma. Cancer. 2005, 105:28-34. 10.1002\/cncr.20764","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.020909","article-title":"Renal medullary carcinoma: establishing standards in practice","volume":"13","author":"Beckermann KE","year":"2017","unstructured":"Beckermann KE, Sharma D, Chaturvedi S, et al.. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract. 2017, 13:414-21. 10.1200\/JOP.2017.020909","journal-title":"J Oncol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31774","article-title":"Contemporary biology, management, and outcomes of renal medullary carcinoma in children and adults: a pediatric surgical oncology research collaborative study","volume":"72","author":"Beckhorn CB","year":"2025","unstructured":"Beckhorn CB, Malek MM, Lovvorn HN, et al.. Contemporary biology, management, and outcomes of renal medullary carcinoma in children and adults: a pediatric surgical oncology research collaborative study. Pediatr Blood Cancer. 2025, 72:e31774. 10.1002\/pbc.31774","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26402","article-title":"Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: two cases","volume":"64","author":"Carden MA","year":"2017","unstructured":"Carden MA, Smith S, Meany H, Yin H, Alazraki A, Rapkin LB. Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: two cases. Pediatr Blood Cancer. 2017, 64:10.1002\/pbc.26402","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2016.08.006","article-title":"Renal medullary carcinoma and sickle cell trait: a push for early diagnosis and intervention report of two cases","volume":"109","author":"Carter SA","year":"2017","unstructured":"Carter SA, Walker AN. Renal medullary carcinoma and sickle cell trait: a push for early diagnosis and intervention report of two cases. J Natl Med Assoc. 2017, 109:63-5. 10.1016\/j.jnma.2016.08.006","journal-title":"J Natl Med Assoc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3324","article-title":"CA-125 as a biomarker in renal medullary carcinoma: integrated molecular profiling, functional characterization, and prospective clinical validation","volume":"31","author":"Grimm SL","year":"2025","unstructured":"Grimm SL, Karki M, Blum KA, et al.. CA-125 as a biomarker in renal medullary carcinoma: integrated molecular profiling, functional characterization, and prospective clinical validation. Clin Cancer Res. 2025, 31:1057-68. 10.1158\/1078-0432.CCR-24-3324","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2023.06.019","article-title":"Renal medullary carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis","volume":"292","author":"Haupt T","year":"2023","unstructured":"Haupt T, Akinyemi O, Raju RA, et al.. Renal medullary carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Surg Res. 2023, 292:1-6. 10.1016\/j.jss.2023.06.019","journal-title":"J Surg Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2013.e44","article-title":"Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil","volume":"5","author":"Maroja Silvino MC","year":"2013","unstructured":"Maroja Silvino MC, Venchiarutti Moniz CM, Munhoz Piotto GH, Siqueira S, Galapo Kann A, Dzik C. Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil. Rare Tumors. 2013, 5:e44. 10.4081\/rt.2013.e44","journal-title":"Rare Tumors"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma","volume":"17","author":"Msaouel P","year":"2019","unstructured":"Msaouel P, Hong AL, Mullen EA, et al.. Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma. Clin Genitourin Cancer. 2019, 17:1-6. 10.1016\/j.clgc.2018.09.005","journal-title":"Clin Genitourin Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137097","article-title":"Recent advances in renal medullary carcinoma","volume":"23","author":"Su Y","year":"2022","unstructured":"Su Y, Hong AL. Recent advances in renal medullary carcinoma. Int J Mol Sci. 2022, 23:10.3390\/ijms23137097","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000455007","article-title":"Renal medullary carcinoma with an aggressive clinical course: a case report and review of the literature","volume":"10","author":"Kalavar MR","year":"2017","unstructured":"Kalavar MR, Ali S, Safarpour D, Kunnakkat SD. Renal medullary carcinoma with an aggressive clinical course: a case report and review of the literature. Case Rep Oncol. 2017, 10:1-7. 10.1159\/000455007","journal-title":"Case Rep Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418419-renal-medullary-carcinoma-a-call-for-screening-and-early-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T16:43:22Z","timestamp":1763225002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418419-renal-medullary-carcinoma-a-call-for-screening-and-early-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.96915","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,15]]}}}